| 1 |
Fecha Nacimiento
[Date] |
min : 1900-12-31
med : 1946-07-24
max : 1983-06-22
range : 82y 5m 22d |
101 distinct values |
 |
101
(98.1%) |
2
(1.9%) |
| 2 |
edadg
[numeric] |
Mean (sd) : 69.7 (13)
min < med < max:
36.5 < 73.4 < 91.9
IQR (CV) : 19 (0.2) |
100 distinct values |
 |
100
(97.1%) |
3
(2.9%) |
| 3 |
edadc
[factor] |
1. (35,50]
2. (50,60]
3. (60,70]
4. (70,80]
5. (80,100] |
| 10 | ( | 10.0% | ) | | 17 | ( | 17.0% | ) | | 16 | ( | 16.0% | ) | | 33 | ( | 33.0% | ) | | 24 | ( | 24.0% | ) |
|
 |
100
(97.1%) |
3
(2.9%) |
| 4 |
Fecha Fallecimiento
[Date] |
min : 2018-07-04
med : 2020-05-02
max : 2021-02-04
range : 2y 7m 0d |
55 distinct values |
 |
56
(54.4%) |
47
(45.6%) |
| 5 |
Sexo
[factor] |
1. Hombre
2. Mujer |
|
 |
101
(98.1%) |
2
(1.9%) |
| 6 |
Fecha dco inicial (recalculado)
[Date] |
min : 2015-11-10
med : 2019-11-06
max : 2021-02-04
range : 5y 2m 25d |
93 distinct values |
 |
101
(98.1%) |
2
(1.9%) |
| 7 |
CEA al diagnóstico:
[character] |
1. 2
2. 3
3. 1
4. 14
5. 17
6. 4
7. 5
8. 6
9. 7
10. 28
[ 47 others ] |
| 6 | ( | 7.0% | ) | | 5 | ( | 5.8% | ) | | 3 | ( | 3.5% | ) | | 3 | ( | 3.5% | ) | | 3 | ( | 3.5% | ) | | 3 | ( | 3.5% | ) | | 3 | ( | 3.5% | ) | | 3 | ( | 3.5% | ) | | 3 | ( | 3.5% | ) | | 2 | ( | 2.3% | ) | | 52 | ( | 60.5% | ) |
|
 |
86
(83.5%) |
17
(16.5%) |
| 8 |
HistologÃa:
[factor] |
1. Adenocarcinoma
2. Adenocarcinoma mucinoso |
|
 |
96
(93.2%) |
7
(6.8%) |
| 9 |
Localización del tumor primario:
[factor] |
1. Colon derecho
2. Colon izquierdo
3. Recto |
| 37 | ( | 35.9% | ) | | 29 | ( | 28.2% | ) | | 37 | ( | 35.9% | ) |
|
 |
103
(100.0%) |
0
(0.0%) |
| 10 |
Esquema 1ª lÃnea:
[factor] |
1. Capecitabina
2. FOLFIRI
3. FOLFOX
4. Irinotecán
5. No aplica
6. TOMOX
7. XELOX |
| 11 | ( | 10.7% | ) | | 1 | ( | 1.0% | ) | | 63 | ( | 61.2% | ) | | 3 | ( | 2.9% | ) | | 19 | ( | 18.4% | ) | | 1 | ( | 1.0% | ) | | 5 | ( | 4.9% | ) |
|
 |
103
(100.0%) |
0
(0.0%) |
| 11 |
Tipo de biológico:
[factor] |
1. antiEGFR
2. antiVEGF
3. Encorafenib
4. No aplica |
| 8 | ( | 32.0% | ) | | 8 | ( | 32.0% | ) | | 1 | ( | 4.0% | ) | | 8 | ( | 32.0% | ) |
|
 |
25
(24.3%) |
78
(75.7%) |
| 12 |
Fecha de inicio:
[Date] |
min : 2019-01-09
med : 2019-05-23
max : 2020-04-22
range : 1y 3m 13d |
15 distinct values |
 |
17
(16.5%) |
86
(83.5%) |
| 13 |
Grupo mutaciones
[factor] |
1. BRAF mutado
2. KRAS-NRAS mutado
3. Otros |
| 6 | ( | 5.8% | ) | | 56 | ( | 54.4% | ) | | 41 | ( | 39.8% | ) |
|
 |
103
(100.0%) |
0
(0.0%) |
| 14 |
Fecha Creacion
[Date] |
min : 2018-07-01
med : 2019-10-21
max : 2021-02-04
range : 2y 7m 3d |
88 distinct values |
 |
103
(100.0%) |
0
(0.0%) |
| 15 |
timetf
[numeric] |
Mean (sd) : 303.6 (243.3)
min < med < max:
-189 < 251 < 1091
IQR (CV) : 290 (0.8) |
92 distinct values |
 |
101
(98.1%) |
2
(1.9%) |
| 16 |
fallece
[logical] |
1. FALSE
2. TRUE |
|
 |
103
(100.0%) |
0
(0.0%) |
